Trial Profile
Autologous Transplantation for Multiple Myeloma: A Research Study of Multiple Myeloma Using Chemotherapy Plus Growth Factor Primed Peripheral Blood Stem Cells Followed by Autologous Transplantation and Post-Transplant Immunotherapy.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Filgrastim (Primary) ; Filgrastim (Primary) ; Carmustine; Cyclophosphamide; Dexamethasone; Etoposide; Interferon alpha; Mitoxantrone; Sargramostim; Sargramostim
- Indications Multiple myeloma
- Focus Therapeutic Use
- 11 Sep 2009 New trial record